Blockchain-Fueled Company Mateon Develops Phase 3 Clinical Drug Candidate, Against COVID-19 – OT-101
Blockchain company Mateon Therapeutics (OTCQB:MATN) has delivered the requisite testing results to Golden Mountain Partners (GMP) confirming the applicability and potential use of OT-101 for the treatment of COVID-19.Amit Shah, CFO of Mateon stated:“I am excited about the potential use of OT-101 against COVID-19. I congratulate the Mateon team on
Read More